GGrantIndex
Sort

34,240 grants matching atherosclerosis

Ambient Air Pollution and Incident Stroke

$652,876
Gregory A Wellenius · Brown University · R01 · FY2012 · ES

Lung Macrophage Memory Development and Responses in Secondary Pneumonia and Sepsis

$652,872
Bibhuti Bhusan Mishra · University Of Texas Hlth Science Center · R01 · FY2023 · AI

Lung Macrophage Memory Development and Responses in Secondary Pneumonia and Sepsis

$652,872
Bibhuti Bhusan Mishra · University Of Texas Hlth Science Center · R01 · FY2024 · AI

GENETICS OF CORONARY ARTERY DISEASE IN ALASKAN NATIVES

$652,865
Medstar Research Institute · U01 · FY2004 · HL

Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection

$652,823
George Tellides · Yale University · R01 · FY2022 · HL

Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection

$652,821
George Tellides · Yale University · R01 · FY2020 · HL

Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection

$652,821
George Tellides · Yale University · R01 · FY2019 · HL

AMPK Regulation of ACE2 in Endothelial Health and Disease

$652,773
John Y-J Shyy · University Of California, San Diego · R01 · FY2024 · HL

Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine Regulation

$652,643
Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI

Diabetes Prevention Program Outcome Study - Phase 2

$652,486
David M Nathan · Massachusetts General Hospital · U01 · FY2011 · DK

Dissecting the role of CD8+ T cells in atherosclerosis

$652,158
Chiara Giannarelli · New York University School Of Medicine · R01 · FY2024 · HL

Metal Exposure and Early Cardiovascular Risk in Adult E-Cigarette Users

$652,086
Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2022 · ES

Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta

$652,072
Alexander Egbe · Mayo Clinic Rochester · R01 · FY2024 · HL

PDGFbeta Receptor Activation Promotes Atheroprotective Changes in SMC Phenotype

$652,024
Gary K Owens · University Of Virginia · R01 · FY2020 · HL

PDGFbeta Receptor Activation Promotes Atheroprotective Changes in SMC Phenotype

$652,024
Gary K Owens · University Of Virginia · R01 · FY2019 · HL

Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State

$651,929
Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2021 · HL

The Role of Layilin as a Novel Regulator of Platelet Activation and Thromboinflammation

$651,800
Aaron Christopher Petrey · University Of Utah · R01 · FY2024 · HL

Computational and functional strategies to decipher lncRNAs in human atherosclerosis

$651,763
Muredach P Reilly · Columbia University Health Sciences · R01 · FY2021 · HL

IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation

$651,703
Xiao-Feng Yang · Temple Univ Of The Commonwealth · R01 · FY2020 · HL

Epidemiology of Venous Thrombosis & Pulmonary Embolism

$651,676
Aaron R Folsom · University Of Minnesota · R01 · FY2009 · HL

Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis

$651,670
Zhenheng Guo · University Of Kentucky · R01 · FY2024 · HL

Raf 1-ERK cross-talk in Arteriogenesis

$651,577
Michael Simons · Yale University · P01 · FY2016 · HL

Optimize Risk Assessment for Incident and Recurrent Atherosclerotic Cardiovascular Disease

$651,548
Yiyi Zhang · Columbia University Health Sciences · R01 · FY2025 · HL

PDGFbeta Receptor Activation Promotes Atheroprotective Changes in SMC Phenotype

$651,534
Gary K Owens · University Of Virginia · R01 · FY2018 · HL

Understanding immune/inflammatory and vascular mechanisms in brain aging and Alzheimer's disease

$651,517
Keenan Walker · National Institute On Aging · ZIA · FY2021 · AG